The nation of Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (£272m) over five years because of Washington's demand for sensitive data.
The decision became public following a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesperson later stated that the United States was demanding access to biological samples for research and commercial purposes while refused to share the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more talks to secure a agreement agreeable to both sides so the country's vital HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court halted a related deal with the US following legal challenges were filed about the safety of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government deals to enhance transparency and accountability.
Based on reports, Sixteen African countries have so far agreed to these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to provide its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," he stated.
"Effectively, our nation would provide the basic resources for medical research with no certainty that the end products would be accessible to our population if a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining frameworks previously established through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage potential pandemics.
"This system is designed to guarantee that when a country provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We welcome further discussions with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but suggested that talks should continue considering a large portion of the nation's HIV programmes depended on international support.
"In cases where technical issues arise, including those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it added.
The situation highlights the ongoing challenges between receiving much-needed international aid and protecting national sovereignty in an ever more data-driven world.